ScholarGate
Βοηθός

Σύγκριση μεθόδων

Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.

Κλινική Δοκιμή Φάσης ΙΙΙ Προσαρμοσμένη στον Κίνδυνο×Αντιστοιχισμένη Τυχαιοποιημένη Ελεγχόμενη Δοκιμή×
ΠεδίοΕπιδημιολογίαΕπιδημιολογία
ΟικογένειαProcess / pipelineProcess / pipeline
Έτος προέλευσης1980s–presentMid-20th century concept; methodological formalization circa 2000–2010
ΔημιουργόςEvolving practice; foundational risk-adjustment principles established by Pocock (1983) and extended by numerous trialistsDeveloped formally in biostatistics literature; Greevy, Imai and colleagues advanced modern frameworks in the 2000s
ΤύποςConfirmatory randomized trial with baseline risk stratification and covariate adjustmentExperimental clinical study design
Θεμελιώδης πηγήPocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley. ISBN: 978-0471901556Imai, K., King, G., & Nall, C. (2009). The essential role of pair matching in cluster-randomized experiments, with application to the Mexican universal health insurance evaluation. Statistical Science, 24(1), 29–53. DOI ↗
Εναλλακτικές ονομασίεςrisk-stratified Phase III trial, covariate-adjusted Phase III RCT, risk-adjusted confirmatory trial, RA-Phase IIImatched RCT, matched-pair randomized trial, matched randomized controlled trial, covariate-matched RCT
Συναφείς66
ΣύνοψηA risk-adjusted Phase III clinical trial is a large-scale confirmatory randomized experiment that explicitly incorporates participants' baseline prognostic risk profile into both the randomization process and the primary statistical analysis. By stratifying patients on known risk factors before allocation and adjusting for those factors in the outcome model, the design achieves greater statistical precision, reduces confounding, and produces treatment effect estimates that are more clinically meaningful across patient subgroups.A matched randomized clinical trial pairs participants (or clusters) on key baseline characteristics before randomization, then allocates one member of each pair to treatment and the other to control. This design combines the causal validity of randomization with the covariate balance of matching, increasing statistical efficiency and reducing confounding from known prognostic variables without sacrificing the internal validity of a controlled experiment.
ScholarGateΣύνολο δεδομένων
  1. v1
  2. 2 Πηγές
  3. PUBLISHED
  1. v1
  2. 2 Πηγές
  3. PUBLISHED

Μετάβαση στην αναζήτηση Λήψη διαφανειών

ScholarGateΣύγκριση μεθόδων: Risk-adjusted Phase III clinical trial · Matched Randomized Clinical Trial. Ανακτήθηκε στις 2026-06-20 από https://scholargate.app/el/compare